Disrupted human-pathogen co-evolution: A model for disease

Frontiers in Genetics

Volumn 5, Issue AUG, 2014, Pages

  Kodaman, Nuri ^a,b   Sobota, Rafal S ^a,b   Mera, Robertino ^c   Schneider, Barbara G ^c   Williams, Scott M ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Genome genome interactions; Helicobacter pylori; Host pathogen coevolution; Human disease; Human papillomavirus; Mycobacterium tuberculosis

Indexed keywords

ANTIBIOTIC AGENT; GUANOSINE TRIPHOSPHATASE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; PROTEIN E6; PROTEIN E7; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; VITAMIN D BINDING PROTEIN;

ARTICLE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; DISEASE PREDISPOSITION; EVOLUTIONARY ADAPTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC RISK; GENETIC SELECTION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GENOTYPE PHENOTYPE CORRELATION; GENOTYPING TECHNIQUE; HELICOBACTER INFECTION; HIGH THROUGHPUT SEQUENCING; HOST PATHOGEN INTERACTION; HUMAN; INNATE IMMUNITY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PAPILLOMAVIRUS INFECTION; PHYLOGENETIC TREE; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS;

EID: 84906233556     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00290     Document Type: Article

References (166)

1. Pallen MJ, Wren BW (2007) Bacterial pathogenomics. Nature 449: 835-842.
2. Rowell JL, Dowling NF, Yu W, Yesupriya A, Zhang L, et al. (2012) Trends in population-based studies of human genetics in infectious diseases. PLoS One 7: e25431.
3. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, et al. (1996) Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382: 722-725.
4. Picard C, Casanova JL, Abel L (2006) Mendelian traits that confer predisposition or resistance to specific infections in humans. Curr Opin Immunol 18: 383-390.
5. Casanova JL, Abel L (2007) Human genetics of infectious diseases: a unified theory. EMBO J 26: 915-922.
6. Hill AV (2001) The genomics and genetics of human infectious disease susceptibility. Annu Rev Genomics Hum Genet 2: 373-400.
7. Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, et al. (2009) Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet 41: 657-665.
8. Ko DC, Urban TJ (2013) Understanding human variation in infectious disease susceptibility through clinical and cellular GWAS. PLoS Pathog 9: e1003424.
9. Hill AV (2012) Evolution, revolution and heresy in the genetics of infectious disease susceptibility. Philos Trans R Soc Lond B Biol Sci 367: 840-849.
10. Wilfert L, Schmid-Hempel P (2008) The genetic architecture of susceptibility to parasites. BMC Evol Biol 8: 187.
11. Monot M, Honore N, Garnier T, Zidane N, Sherafi D, et al. (2009) Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat Genet 41: 1282-1289.
12. Anderson RM, May RM (1982) Coevolution of hosts and parasites. Parasitology 85 (Pt 2): 411-426.
13. Messenger SL, Molineux IJ, Bull JJ (1999) Virulence evolution in a virus obeys a trade-off. Proc Biol Sci 266: 397-404.
14. Frank SA (1996) Models of parasite virulence. Q Rev Biol 71: 37-78.
15. Blaser MJ, Kirschner D (2007) The equilibria that allow bacterial persistence in human hosts. Nature 449: 843-849.
16. Frank SA, Schmid-Hempel P (2008) Mechanisms of pathogenesis and the evolution of parasite virulence. J Evol Biol 21: 396-404.
17. Lambrechts L, Fellous S, Koella JC (2006) Coevolutionary interactions between host and parasite genotypes. Trends Parasitol 22: 12-16.
18. Jacob F (1977) Evolution and tinkering. Science 196: 1161-1166.
19. Thompson JN, Nuismer SL, Gomulkiewicz R (2002) Coevolution and maladaptation. Integr Comp Biol 42: 381-387.
20. Thompson JN (2014) Natural selection, coevolution, and the web of life. Am Nat 183: iv-v.
21. Ridenhour BJ, Nuismer SL (2007) Polygenic traits and parasite local adaptation. Evolution 61: 368-376.
22. Woolhouse ME, Webster JP, Domingo E, Charlesworth B, Levin BR (2002) Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat Genet 32: 569-577.
23. Little TJ, Watt K, Ebert D (2006) Parasite-host specificity: experimental studies on the basis of parasite adaptation. Evolution 60: 31-38.
24. Little TJ (2002) The evolutionary significance of parasitism: do parasite-driven genetic dynamics occur ex silico? J Evol Biol 15: 1-9
25. Lenski RE, Levin BR (1985) Constraints on the Coevolution of Bacteria and Virulent Phage - a Model, Some Experiments, and Predictions for Natural Communities. American Naturalist 125: 585-602.
26. Funk DJ, Helbling L, Wernegreen JJ, Moran NA (2000) Intraspecific phylogenetic congruence among multiple symbiont genomes. Proc Biol Sci 267: 2517-2521.
27. Kraaijeveld AR, Van Alphen JJ, Godfray HC (1998) The coevolution of host resistance and parasitoid virulence. Parasitology 116 Suppl: S29-45.
28. Lively CM, Dybdahl MF (2000) Parasite adaptation to locally common host genotypes. Nature 405: 679-681.
29. Peek RM, Jr., Blaser MJ (2002) Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2: 28-37.
30. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
31. Blaser MJ, Chen Y, Reibman J (2008) Does Helicobacter pylori protect against asthma and allergy? Gut 57: 561-567
32. Rothenbacher D, Blaser MJ, Bode G, Brenner H (2000) Inverse relationship between gastric colonization of Helicobacter pylori and diarrheal illnesses in children: results of a populationbased cross-sectional study. J Infect Dis 182: 1446-1449.
33. Vaezi MF, Falk GW, Peek RM, Vicari JJ, Goldblum JR, et al. (2000) CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am J Gastroenterol 95: 2206-2211.
34. Moodley Y, Linz B, Bond RP, Nieuwoudt M, Soodyall H, et al. (2012) Age of the association between Helicobacter pylori and man. PLoS Pathog 8: e1002693.
35. Rothenbacher D, Winkler M, Gonser T, Adler G, Brenner H (2002) Role of infected parents in transmission of helicobacter pylori to their children. Pediatr Infect Dis J 21: 674-679.
36. Susser M, Stein Z (2002) Civilization and peptic ulcer. International Journal of Epidemiology 31: 13-17.
37. Correa P, Cuello C, Duque E, Burbano LC, Garcia FT, et al. (1976) Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst 57: 1027-1035.
38. Ewald PW, Cochran GM (2000) Chlamydia pneumoniae and cardiovascular disease: an evolutionary perspective on infectious causation and antibiotic treatment. J Infect Dis 181 Suppl 3: S394-401.
39. Cochran GM, Ewald PW, Cochran KD (2000) Infectious causation of disease: an evolutionary perspective. Perspect Biol Med 43: 406-448.
40. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, et al. (2003) Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95: 1404-1413.
41. Wroblewski LE, Peek RM, Jr., Wilson KT (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23: 713-739.
42. Salama NR, Hartung ML, Muller A (2013) Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nature Reviews Microbiology 11: 385-399.
43. Baldari CT, Lanzavecchia A, Telford JL (2005) Immune subversion by Helicobacter pylori. Trends Immunol 26: 199-207.
44. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. (2000) Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland. New England Journal of Medicine 343: 78-85.
45. Chiba T, Seno H, Marusawa H, Wakatsuki Y, Okazaki K (2006) Host factors are important in determining clinical outcomes of Helicobacter pylori infection. J Gastroenterol 41: 1-9.
46. Mayerle J, den Hoed CM, Schurmann C, Stolk L, Homuth G, et al. (2013) Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA 309: 1912-1920.
47. Schneider BG, Camargo MC, Ryckman KK, Sicinschi LA, Piazuelo MB, et al. (2008) Cytokine polymorphisms and gastric cancer risk. Cancer Biology & Therapy 7: 157-162.
48. Shi Y, Hu Z, Wu C, Dai J, Li H, et al. (2011) A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet 43: 1215-1218.
49. El-Omar EM (2013) Helicobacter pylori susceptibility in the GWAS era. JAMA 309: 1939-1940.
50. Mayerle J, Kuipers EJ, Lerch MM (2013) Genetic variants associated with susceptibility to Helicobacter pylori--reply. JAMA 310: 976-977.
51. Holcombe C (1992) Helicobacter pylori: the African enigma. Gut 33: 429-431.
52. Ghoshal UC, Tripathi S, Ghoshal U (2007) The Indian enigma of frequent H. pylori infection but infrequent gastric cancer: is the magic key in Indian diet, host's genetic make up, or friendly bug? Am J Gastroenterol 102: 2113-2114.
53. Campbell DI, Warren BF, Thomas JE, Figura N, Telford JL, et al. (2001) The African enigma: low prevalence of gastric atrophy, high prevalence of chronic inflammation in West African adults and children. Helicobacter 6: 263-267.
54. Correa P, Piazuelo MB (2012) Evolutionary History of the Helicobacter pylori Genome: Implications for Gastric Carcinogenesis. Gut Liver 6: 21-28.
55. Dominguez-Bello MG, Perez ME, Bortolini MC, Salzano FM, Pericchi LR, et al. (2008) Amerindian Helicobacter pylori strains go extinct, as european strains expand their host range. PLoS One 3: e3307.
56. Torres J, Correa P, Ferreccio C, Hernandez-Suarez G, Herrero R, et al. (2013) Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America. Cancer Causes Control 24: 249-256.
57. de Sablet T, Piazuelo MB, Shaffer CL, Schneider BG, Asim M, et al. (2011) Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut 60: 1189-1195.
58. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, et al. (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95: 3140-3145.
59. Falush D, Wirth T, Linz B, Pritchard JK, Stephens M, et al. (2003) Traces of human migrations in Helicobacter pylori populations. Science 299: 1582-1585.
60. Moodley Y, Linz B (2009) Helicobacter pylori Sequences Reflect Past Human Migrations. Genome Dyn 6: 62-74.
61. Moodley Y, Linz B, Yamaoka Y, Windsor HM, Breurec S, et al. (2009) The peopling of the Pacific from a bacterial perspective. Science 323: 527-530.
62. Suerbaum S, Smith JM, Bapumia K, Morelli G, Smith NH, et al. (1998) Free recombination within Helicobacter pylori. Proc Natl Acad Sci U S A 95: 12619-12624.
63. Kodaman N, Pazos A, Schneider BG, Piazuelo MB, Mera R, et al. (2014) Human and Helicobacter pylori coevolution shapes the risk of gastric disease. Proc Natl Acad Sci U S A 111: 1455-1460.
64. Wirth T, Wang X, Linz B, Novick RP, Lum JK, et al. (2004) Distinguishing human ethnic groups by means of sequences from Helicobacter pylori: lessons from Ladakh. Proc Natl Acad Sci U S A 101: 4746-4751.
65. Dorer MS, Talarico S, Salama NR (2009) Helicobacter pylori's unconventional role in health and disease. PLoS Pathog 5: e1000544.
66. Israel DA, Salama N, Krishna U, Rieger UM, Atherton JC, et al. (2001) Helicobacter pylori genetic diversity within the gastric niche of a single human host. Proc Natl Acad Sci U S A 98: 14625-14630.
67. Gressmann H, Linz B, Ghai R, Pleissner KP, Schlapbach R, et al. (2005) Gain and loss of multiple genes during the evolution of Helicobacter pylori. PLoS Genet 1: e43.
68. Salama N, Guillemin K, McDaniel TK, Sherlock G, Tompkins L, et al. (2000) A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc Natl Acad Sci U S A 97: 14668-14673.
69. Aspholm-Hurtig M, Dailide G, Lahmann M, Kalia A, Ilver D, et al. (2004) Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science 305: 519-522.
70. Backstrom A, Lundberg C, Kersulyte D, Berg DE, Boren T, et al. (2004) Metastability of Helicobacter pylori bab adhesin genes and dynamics in Lewis b antigen binding. Proc Natl Acad Sci U S A 101: 16923-16928.
71. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, et al. (2006) Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A 103: 732-737.
72. Hung IF, Wong BC (2009) Assessing the risks and benefits of treating helicobacter pylori infection. Therap Adv Gastroenterol 2: 141-147.
73. Comas I, Coscolla M, Luo T, Borrell S, Holt KE, et al. (2013) Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet 45: 1176-1182.
74. Dye C, Williams BG (2010) The population dynamics and control of tuberculosis. Science 328: 856-861.
75. Fenner L, Egger M, Bodmer T, Furrer H, Ballif M, et al. (2013) HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis. PLoS Genet 9: e1003318.
76. Barry CE, 3rd, Boshoff HI, Dartois V, Dick T, Ehrt S, et al. (2009) The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 7: 845-855.
77. Knolle H (1989) Host density and the evolution of parasite virulence. J Theor Biol 136: 199-207.
78. Achtman M (2008) Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens. Annu Rev Microbiol 62: 53-70.
79. Galagan JE (2014) Genomic insights into tuberculosis. Nat Rev Genet 15: 307-320.
80. Comstock GW (1978) Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 117: 621-624.
81. Moller M, Hoal EG (2010) Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis (Edinb) 90: 71-83.
82. Lewis SJ, Baker I, Davey Smith G (2005) Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. Int J Tuberc Lung Dis 9: 1174-1177.
83. Gao L, Tao Y, Zhang L, Jin Q (2010) Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis 14: 15-23.
84. Hoal EG, Lewis LA, Jamieson SE, Tanzer F, Rossouw M, et al. (2004) SLC11A1 (NRAMP1) but not SLC11A2 (NRAMP2) polymorphisms are associated with susceptibility to tuberculosis in a highincidence community in South Africa. Int J Tuberc Lung Dis 8: 1464-1471.
85. Velez DR, Hulme WF, Myers JL, Stryjewski ME, Abbate E, et al. (2009) Association of SLC11A1 with tuberculosis and interactions with NOS2A and TLR2 in African-Americans and Caucasians. Int J Tuberc Lung Dis 13: 1068-1076.
86. Barreiro LB, Neyrolles O, Babb CL, Tailleux L, Quach H, et al. (2006) Promoter variation in the DCSIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med 3: e20.
87. Olesen R, Wejse C, Velez DR, Bisseye C, Sodemann M, et al. (2007) DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun 8: 456-467.
88. Chimusa ER, Zaitlen N, Daya M, Moller M, van Helden PD, et al. (2014) Genome-wide association study of ancestry-specific TB risk in the South African Coloured population. Hum Mol Genet 23: 796-809.
89. Thye T, Vannberg FO, Wong SH, Owusu-Dabo E, Osei I, et al. (2010) Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet 42: 739-741.
90. Thye T, Owusu-Dabo E, Vannberg FO, van Crevel R, Curtis J, et al. (2012) Common variants at 11p13 are associated with susceptibility to tuberculosis. Nat Genet 44: 257-259.
91. Nicol MP, Wilkinson RJ (2008) The clinical consequences of strain diversity in Mycobacterium tuberculosis. Trans R Soc Trop Med Hyg 102: 955-965.
92. Malik AN, Godfrey-Faussett P (2005) Effects of genetic variability of Mycobacterium tuberculosis strains on the presentation of disease. Lancet Infect Dis 5: 174-183.
93. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D (2002) Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 8: 843-849.
94. Reed MB, Domenech P, Manca C, Su H, Barczak AK, et al. (2004) A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431: 84-87.
95. Parwati I, van Crevel R, van Soolingen D (2010) Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis 10: 103-111.
96. Stucki D, Gagneux S (2013) Single nucleotide polymorphisms in Mycobacterium tuberculosis and the need for a curated database. Tuberculosis (Edinb) 93: 30-39.
97. Reiling N, Homolka S, Walter K, Brandenburg J, Niwinski L, et al. (2013) Clade-specific virulence patterns of Mycobacterium tuberculosis complex strains in human primary macrophages and aerogenically infected mice. MBio 4.
98. Hershberg R, Lipatov M, Small PM, Sheffer H, Niemann S, et al. (2008) High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol 6: e311.
99. de Jong BC, Antonio M, Gagneux S (2010) Mycobacterium africanum--review of an important cause of human tuberculosis in West Africa. PLoS Negl Trop Dis 4: e744.
100. Portevin D, Gagneux S, Comas I, Young D (2011) Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog 7: e1001307.
101. Coscolla M, Gagneux S (2010) Does M. tuberculosis genomic diversity explain disease diversity? Drug Discov Today Dis Mech 7: e43-e59.
102. Comas I, Gagneux S (2011) A role for systems epidemiology in tuberculosis research. Trends Microbiol 19: 492-500.
103. de Jong BC, Hill PC, Aiken A, Awine T, Antonio M, et al. (2008) Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis 198: 1037-1043.
104. Gagneux S (2012) Host-pathogen coevolution in human tuberculosis. Philos Trans R Soc Lond B Biol Sci 367: 850-859.
105. Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NT, et al. (2008) The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 4: e1000034.
106. Intemann CD, Thye T, Niemann S, Browne EN, Amanua Chinbuah M, et al. (2009) Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathog 5: e1000577.
107. Herb F, Thye T, Niemann S, Browne EN, Chinbuah MA, et al. (2008) ALOX5 variants associated with susceptibility to human pulmonary tuberculosis. Hum Mol Genet 17: 1052-1060.
108. Thye T, Niemann S, Walter K, Homolka S, Intemann CD, et al. (2011) Variant G57E of mannose binding lectin associated with protection against tuberculosis caused by Mycobacterium africanum but not by M. tuberculosis. PLoS One 6: e20908.
109. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, et al. (2006) Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 103: 2869-2873.
110. Sharma SK, Mohan A (2004) Extrapulmonary tuberculosis. Indian J Med Res 120: 316-353.
111. Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ (2011) Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One 6: e17601.
112. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, et al. (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13: 607-615.
113. zur Hausen H (1989) Papillomavirus in anogenital cancer: the dilemma of epidemiologic approaches. J Natl Cancer Inst 81: 1680-1682.
114. zur Hausen H (1991) Viruses in human cancers. Science 254: 1167-1173.
115. Carter JJ, Madeleine MM, Shera K, Schwartz SM, Cushing-Haugen KL, et al. (2001) Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res 61: 1934-1940.
116. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, et al. (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401: 70-79.
117. Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, et al. (2005) The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337: 76-84.
118. Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM, et al. (2007) A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 195: 1582-1589.
119. Ong CK, Chan SY, Campo MS, Fujinaga K, Mavromara-Nazos P, et al. (1993) Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 67: 6424-6431.
120. Shah SD, Doorbar J, Goldstein RA (2010) Analysis of host-parasite incongruence in papillomavirus evolution using importance sampling. Mol Biol Evol 27: 1301-1314.
121. Rector A, Lemey P, Tachezy R, Mostmans S, Ghim SJ, et al. (2007) Ancient papillomavirus-host cospeciation in Felidae. Genome Biol 8: R57.
122. Van Doorslaer K (2013) Evolution of the papillomaviridae. Virology 445: 11-20.
123. Herbst LH, Lenz J, Van Doorslaer K, Chen Z, Stacy BA, et al. (2009) Genomic characterization of two novel reptilian papillomaviruses, Chelonia mydas papillomavirus 1 and Caretta caretta papillomavirus 1. Virology 383: 131-135.
124. Lewin R (1993). Human Evolution. 3 ed. Boston: Blackwell Scientific Publications.
125. Bernard HU (1994) Coevolution of papillomaviruses with human populations. Trends Microbiol 2: 140-143.
126. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, et al. (1993) The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 67: 6413-6423.
127. Garcia-Vallve S, Alonso A, Bravo IG (2005) Papillomaviruses: different genes have different histories. Trends Microbiol 13: 514-521.
128. Chen Z, Terai M, Fu L, Herrero R, DeSalle R, et al. (2005) Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol 79: 7014-7023.
129. Carvajal-Rodriguez A (2008) Detecting recombination and diversifying selection in human alphapapillomavirus. Infect Genet Evol 8: 689-692.
130. DeFilippis VR, Ayala FJ, Villarreal LP (2002) Evidence of diversifying selection in human papillomavirus type 16 E6 but not E7 oncogenes. J Mol Evol 55: 491-499.
131. Doorbar J (2006) Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 110: 525-541.
132. White AE, Livanos EM, Tlsty TD (1994) Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev 8: 666-677.
133. Klingelhutz AJ, Roman A (2012) Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. Virology 424: 77-98.
134. Dyson N, Howley PM, Munger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-937.
135. Huibregtse JM, Scheffner M, Howley PM (1993) Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol 13: 4918-4927.
136. Huibregtse JM, Scheffner M, Howley PM (1993) Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol 13: 775-784.
137. Munger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, et al. (2004) Mechanisms of human papillomavirus-induced oncogenesis. J Virol 78: 11451-11460.
138. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, et al. (1998) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229-234.
139. Hildesheim A, Wang SS (2002) Host and viral genetics and risk of cervical cancer: a review. Virus Res 89: 229-240.
140. Wheeler CM (2008) Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer. Obstet Gynecol Clin North Am 35: 519-536; vii.
141. Magnusson PK, Lichtenstein P, Gyllensten UB (2000) Heritability of cervical tumours. Int J Cancer 88: 698-701.
142. Shi Y, Li L, Hu Z, Li S, Wang S, et al. (2013) A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. Nat Genet 45: 918-922.
143. Chen D, Juko-Pecirep I, Hammer J, Ivansson E, Enroth S, et al. (2013) Genome-wide association study of susceptibility loci for cervical cancer. J Natl Cancer Inst 105: 624-633.
144. Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, et al. (2004) Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol 74: 117-126.
145. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, et al. (1997) Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89: 796-802.
146. Sokurenko EV, Gomulkiewicz R, Dykhuizen DE (2006) Source-sink dynamics of virulence evolution. Nat Rev Microbiol 4: 548-555.
147. Falush D (2009) Toward the use of genomics to study microevolutionary change in bacteria. PLoS Genet 5: e1000627.
148. Ajzenberg D, Banuls AL, Su C, Dumetre A, Demar M, et al. (2004) Genetic diversity, clonality and sexuality in Toxoplasma gondii. International Journal for Parasitology 34: 1185-1196.
149. Bull JJ, Molineux IJ, Rice WR (1991) Selection of Benevolence in a Host-Parasite System. Evolution 45: 875-882.
150. Heitman J (2006) Sexual reproduction and the evolution of microbial pathogens. Curr Biol 16: R711-725.
151. Grigg ME, Bonnefoy S, Hehl AB, Suzuki Y, Boothroyd JC (2001) Success and virulence in toxoplasma as the result of sexual recombination between two distinct ancestries. Science 294: 161-165.
152. Liu L, Chen X, Skogerbo G, Zhang P, Chen R, et al. (2012) The human microbiome: a hot spot of microbial horizontal gene transfer. Genomics 100: 265-270.
153. Smillie CS, Smith MB, Friedman J, Cordero OX, David LA, et al. (2011) Ecology drives a global network of gene exchange connecting the human microbiome. Nature 480: 241-244.
154. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, et al. (2011) Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A 108 Suppl 1: 4680-4687.
155. [2012] Structure, function and diversity of the healthy human microbiome. Nature 486: 207-214.
156. Benson AK, Kelly SA, Legge R, Ma F, Low SJ, et al. (2010) Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci U S A 107: 18933-18938.
157. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, et al. (2009) A core gut microbiome in obese and lean twins. Nature 457: 480-484.
158. McFall-Ngai M, Hadfield MG, Bosch TC, Carey HV, Domazet-Loso T, et al. (2013) Animals in a bacterial world, a new imperative for the life sciences. Proc Natl Acad Sci U S A 110: 3229-3236.
159. Karlsson EK, Kwiatkowski DP, Sabeti PC (2014) Natural selection and infectious disease in human populations. Nat Rev Genet 15: 379-393.
160. Aguileta G, Refregier G, Yockteng R, Fournier E, Giraud T (2009) Rapidly evolving genes in pathogens: methods for detecting positive selection and examples among fungi, bacteria, viruses and protists. Infect Genet Evol 9: 656-670.
161. Bartha I, Carlson JM, Brumme CJ, McLaren PJ, Brumme ZL, et al. (2013) A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control. Elife (Cambridge) 2: e01123.
162. Porta C, Riboldi E, Sica A (2011) Mechanisms linking pathogens-associated inflammation and cancer. Cancer Lett 305: 250-262.
163. Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105: 1135-1143.
164. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, et al. (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491: 56-65.
165. [2005] A haplotype map of the human genome. Nature 437: 1299-1320.
166. Cavalli-Sforza LL (2005) The Human Genome Diversity Project: past, present and future. Nat Rev Genet 6: 333-340.